谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Safety, Tolerability, and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection: Study Protocol for a Phase 2 Trial

Mayer Katharina A.,Budde Klemens,Halloran Philip F.,Doberer Konstantin,Rostaing Lionel,Eskandary Farsad,Christamentl Anna,Wahrmann Markus,Regele Heinz,Schranz Sabine,Ely Sarah,Firbas Christa,Schörgenhofer Christian,Kainz Alexander,Loupy Alexandre,Härtle Stefan,Boxhammer Rainer,Jilma Bernd,Böhmig Georg A.

Trials（2022）

引用 6|浏览22
暂无评分
关键词
Antibody-mediated rejection,CD38,Donor-specific antibody,Felzartamab,Kidney transplantation,Monoclonal antibody,Natural killer cell,Plasma cell
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要